Ilhan Avni Bayhan

Ilhan Avni Bayhan

Auto-generated profile, based on publicly available information

Ilhan Avni Bayhan

Department of Orthopedics, Health Science University Baltalimani Bone Diseases Education and Research Hospital, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2016 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
YBYavuz Bayram
Yavuz Bayram
EKEnder Karaca
Ender Karaca
ZAZeynep Coban Akdemir
Zeynep Coban Akdemir
EYElif Ozdamar Yilmaz
Elif Ozdamar Yilmaz
GTGulsen Akay Tayfun
Gulsen Akay Tayfun
JLJames Lupski
James Lupski
BACKGROUND. Arthrogryposis, defined as congenital joint contractures in 2 or more body areas, is a clinical sign rather than a specific disease diagnosis. To date, more than 400 different disorders have been described that present with arthrogryposis, and variants of more than 220 genes have been associated with these disorders; however, the underlying molecular etiology remains unknown in the considerable majority of these cases. METHODS. We performed whole exome sequencing (WES) of 52 patients with clinical presentation of arthrogryposis from 48 different families. RESULTS. Affected individuals from 17 families (35.4%) had variants in known arthrogryposis-associated genes, including homozygous variants of cholinergic γ nicotinic receptor (CHRNG, 6 subjects) and endothelin converting enzyme–like 1 (ECEL1, 4 subjects). Deleterious variants in candidate arthrogryposis-causing genes (fibrillin 3 [FBN3], myosin IXA [MYO9A], and pleckstrin and Sec7 domain containing 3 [PSD3]) were identified in 3 families (6.2%). Moreover, in 8 families with a homozygous mutation in an arthrogryposis-associated gene, we identified a second locus with either a homozygous or compound heterozygous variant in a candidate gene (myosin binding protein C, fast type [MYBPC2] and vacuolar protein sorting 8 [VPS8], 2 families, 4.2%) or in another disease-associated genes (6 families, 12.5%), indicating a potential mutational burden contributing to disease expression. CONCLUSION. In 58.3% of families, the arthrogryposis manifestation could be explained by a molecular diagnosis; however, the molecular etiology in subjects from 20 families remained unsolved by WES. Only 5 of these 20 unrelated subjects had a clinical presentation consistent with amyoplasia; a phenotype not thought to be of genetic origin. Our results indicate that increased use of genome-wide technologies will provide opportunities to better understand genetic models for diseases and molecular mechanisms of genetically heterogeneous disorders, such as arthrogryposis. FUNDING. This work was supported in part by US National Human Genome Research Institute (NHGRI)/National Heart, Lung, and Blood Institute (NHLBI) grant U54HG006542 to the Baylor-Hopkins Center for Mendelian Genomics, and US National Institute of Neurological Disorders and Stroke (NINDS) grant R01NS058529 to J.R. Lupski.

1 July 2019 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
DPDavut Pehlivan
Davut Pehlivan
YBYavuz Bayram
Yavuz Bayram
NGNilay Gunes
Nilay Gunes
ZAZeynep Coban Akdemir
Zeynep Coban Akdemir
ASAnju Shukla
Anju Shukla
JLJames Lupski
James Lupski

26 September 2015 in European Spine Journal
Verified
Journal Article
Closed access
PDF file
TNTristan Nishnianidze
Tristan Nishnianidze
IBIlhan A. Bayhan
Ilhan A. Bayhan
OAOussama Abousamra
Oussama Abousamra
JSJulieanne Sees
Julieanne Sees
KRKenneth J. Rogers
Kenneth J. Rogers
FMFreeman Miller
Freeman Miller

15 July 2020 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
MIMustafa A. İnCesoy
Mustafa A. İnCesoy
KYKadir İ. Yıldız
Kadir İ. Yıldız
ÖTÖzgür İ. Türk
Özgür İ. Türk
ŞAŞuayip Akıncı
Şuayip Akıncı
ETEmre Turgut
Emre Turgut
IBIlhan A. Bayhan
Ilhan A. Bayhan

1 April 2016 in Journal of Pediatric Orthopaedics
Verified
Journal Article
Closed access
IBIlhan A. Bayhan
Ilhan A. Bayhan
JSJulieanne P. Sees
Julieanne P. Sees
TNTristan Nishnianidze
Tristan Nishnianidze
KRKenneth J. Rogers
Kenneth J. Rogers
FMFreeman Miller
Freeman Miller
Children with cerebral palsy (CP) and spasticity are often managed with intrathecal baclofen treatment (ITB). Complications of ITB include infection at the pump or catheter site and late complications as well as revisions of the pump and catheter because of events such as battery expiration or implant malfunction. The goal of this study is to report the short-term and long-term incidence, risk factors, and treatment outcomes of ITB infections in children. This was a retrospective review of 294 children with CP. The number of ITB surgeries per patient, risk of infection for primary and secondary ITB-related procedures, microorganisms responsible, and associated factors, such as concurrent orthopaedic interventions, medical comorbidities, and subsequent management of ITB-related infections, were evaluated. Infection occurred in 28/294 patients (9.5%) with a 4.9% rate per procedure. There were 14 acute (within 90 d of surgery) and 14 late infections. The infection risk per ITB procedure was 2.4%. Risk of late infection over 5-year mean follow-up was 0.95% per year. Pump removal with acute contralateral implantation was the most successful treatment of infections. Gross Motor Function Classification System level V and G-tube were the main risk factors for infection. A total of 133 concurrent orthopaedic procedures were performed during 277 ITB procedures with no increased risk of infection. ITB in children with CP has a relatively low and manageable risk of infection. It is important to always consider infection as a complication with ITB because with prompt treatment the positive impact of ITB is still possible. It is safe to perform concurrent orthopaedic procedures with ITB procedures. Level III-therapeutic study.

6 February 2020 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
YAYakup Alpay
Yakup Alpay
AEAtakan Ezici
Atakan Ezici
MKMuhammed Bilal Kurk
Muhammed Bilal Kurk
OOOsman Nuri Ozyalvac
Osman Nuri Ozyalvac
EAEvren Akpinar
Evren Akpinar
ABAvni Ilhan Bayhan
Avni Ilhan Bayhan